TGTX icon

TG Therapeutics

135 hedge funds and large institutions have $646M invested in TG Therapeutics in 2019 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 45 increasing their positions, 31 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
135
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$35.8M
Puts
$8.12M
Net Calls
Net Calls Change

Top Buyers

1 +$60.3M
2 +$33.3M
3 +$11.9M
4
ACA
Avoro Capital Advisors
New York
+$11.1M
5
Alkeon Capital Management
Alkeon Capital Management
New York
+$11.1M

Top Sellers

1 -$49.1M
2 -$10.2M
3 -$5.98M
4
State Street
State Street
Massachusetts
-$5.61M
5
BM
Bridger Management
New York
-$4.74M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$1.1M
52
$1.01M
53
$1.01M
54
$1M
55
$860K
56
$781K
57
$700K
58
$699K
59
$666K
60
$631K
61
$628K
62
$614K
63
$599K
64
$582K
65
$576K
66
$542K
67
$535K
68
$527K
69
$490K
70
$464K
71
$461K
72
$453K
73
$451K
74
$440K
75
$428K